Pilot 2: Glucagon-like Peptide-1 in Sleep Disordered Breathing
Phase of Trial: Phase I/II
Latest Information Update: 19 Apr 2016
At a glance
- Drugs Liraglutide (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Apr 2016 Status changed from active, no longer recruiting to completed.
- 03 Aug 2015 Planned number of patients changed from 20 to 30 as per ClinicalTrials.gov record.